v3.25.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2025
Revenue  
Schedule of Net product revenue in United States, and Company's net revenue

Three Months Ended

March 31, 

(in thousands)

    

2025

2024

LOQTORZI

$

7,348

$

1,988

Other revenue

 

251

 

320

Total net revenue

$

7,599

$

2,308

Schedule of Gross Revenues by Significant Customer as a Percentage of Total Gross Revenues

Three Months Ended

 

March 31, 

2025

 

2024

 

McKesson Corporation

46

%

29

%

Cencora (previously known as AmeriSource-Bergen Corporation)

33

%

43

%

Cardinal Health, Inc.

20

%

24

%

Schedule of Activities and Ending Reserve Balances for Each Significant Category of Discounts and Allowances

Three Months Ended March 31, 2025

    

Chargebacks

    

    

Other Fees,

    

and Discounts

Co-pay

for Prompt

Assistance

(in thousands)

Payment

Rebates

and Returns

Total

Balances at December 31, 2024

$

110,778

$

123,738

$

41,129

$

275,645

Provision related to sales made in:

Current period

139,766

34,476

22,611

196,853

Prior period - increase (decrease)

797

3,545

(773)

3,569

Payments and customer credits issued

 

(182,426)

(47,061)

(29,927)

(259,414)

Balances at March 31, 2025

$

68,915

$

114,698

$

33,040

$

216,653

Three Months Ended March 31, 2024

    

Chargebacks

    

    

Other Fees,

    

and Discounts

Co-pay

for Prompt

Assistance

(in thousands)

Payment

Rebates

and Returns

Total

Balances at December 31, 2023

$

73,953

$

121,137

$

49,795

$

244,885

Provision related to sales made in:

Current period

 

223,619

56,432

42,359

322,410

Prior period - increase (decrease)

(504)

1,399

410

1,305

Payments and customer credits issued

 

(228,278)

 

(74,958)

 

(40,799)

 

(344,035)

Balances at March 31, 2024

$

68,790

$

104,010

$

51,765

$

224,565